Skip to main contentSkip to navigation
Sirius Investors
Patient Access Solutions, Inc.

Patient Access Solutions, Inc.

PASO
OTCHealthcare

Market Capitalization & Enterprise Value

Research-grade valuation history for PASO. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.

Market Cap & Enterprise Value

Comparison of market capitalization and enterprise value over time

Market Cap

Market Capitalization = Stock Price × Number of Shares Outstanding. Represents the total value of a company's equity.
8.20M
+96.72% over period
CAGR: +14.48%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Enterprise Value

Enterprise Value = Market Cap + Total Debt - Cash and Cash Equivalents. Represents the total value of a company including its debt.
9.11M
+105.24% over period
CAGR: +15.46%
Compound Annual Growth Rate - The mean annual growth rate over time, accounting for compounding effects.

Market Cap History

Investor Valuation Insights

As of Jan 31, 2022

EV/EBITDA

Potentially Rich

19423.34x

Higher EV/EBITDA may imply premium pricing; growth durability should justify the multiple.

EV vs Market Cap Spread

910.35K

EV is +11.1% vs equity value

Capital Structure Signal

Net Debt Profile

EV premium trend: +4.6 pp vs earliest data

Additional Multiples

EV/Sales: 108.91x

Net Debt/EBITDA: 3062.45x

Share count change in dataset: +9184.29%

Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.

Market Cap & Enterprise Value Data

Free users can view the latest 3 records. Upgrade to see full history.

Upgrade
DateMarket CapEnterprise ValueStock PriceShares
Oct 31, 20218.20M9.11M$0.002.28B
Oct 31, 202033.58M34.50M$0.031.16B
Oct 31, 20195.26M5.79M$0.01389.75M
Oct 31, 2018
Oct 31, 2017
Oct 31, 2016

Enterprise Value Analysis

Price Change (Oct 2020 to Oct 2021)

The stock price has decreased from Oct 2020 to Oct 2021.
-87.59%

Recent Volatility

The stock price has been relatively volatile over the last 5 periods, indicating a higher risk profile.
0.90

Risk-Adjusted Return

The stock's returns do not compensate for its risk level, suggesting a poor risk-reward profile.
-0.05

Market Cap Change (Oct 2020 to Oct 2021)

The company's market capitalization has decreased from Oct 2020 to Oct 2021.
-75.59%

Enterprise Value Change (Oct 2020 to Oct 2021)

The company's enterprise value has decreased from Oct 2020 to Oct 2021, suggesting a decline in the company's total economic value.
-73.60%

Market Cap vs. Enterprise Value

A higher enterprise value growth rate compared to market cap growth could indicate that the company is investing heavily in growth initiatives or taking on more debt.
EV Growth > Market Cap Growth

Market Cap CAGR

The Compound Annual Growth Rate (CAGR) of market capitalization represents the mean annual growth rate over the entire available history (6 periods), accounting for compounding effects.
14.48%

Enterprise Value CAGR

The Compound Annual Growth Rate (CAGR) of enterprise value represents the mean annual growth rate over the entire available history (6 periods), accounting for compounding effects.
15.46%